L. Foster

发表

Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial

A. Demchuk, J. Broderick, D. Liebeskind, 2015, Stroke.

ASPECTS score to select patients for endovascular treatment: the IMS-III trial

A. Demchuk, J. Broderick, T. Tomsick, 2014 .

The role of endoscopy and findings in COVID-19 patients, an early North American Cohort

Vikesh K. Singh, A. Chak, W. Tierney, 2021, BMC Gastroenterology.

Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

S. Yusuf, R. Sacco, H. Diener, 2012, European heart journal.

Multimodal CT Imaging: Time to Treatment and Outcomes in the IMS III Trial

A. Demchuk, T. Tomsick, M. Hill, 2016, American Journal of Neuroradiology.

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial.

A. Demchuk, J. Broderick, K. Cockroft, 2014, Radiology.

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes

A. Demchuk, J. Broderick, D. Liebeskind, 2017, American Journal of Neuroradiology.

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions

A. Demchuk, J. Broderick, D. Liebeskind, 2014, Journal of NeuroInterventional Surgery.

Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials

A. Demchuk, C. Anderson, J. Broderick, 2014, Stroke.

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

J. Broderick, T. Tomsick, Y. Palesch, 2016, Interventional Neurology.

Association Between CT Angiogram Collaterals and CT Perfusion in the Interventional Management of Stroke III Trial

A. Demchuk, D. Liebeskind, T. Tomsick, 2016, Stroke.

Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial

A. Demchuk, J. Broderick, D. Liebeskind, 2015, American Journal of Neuroradiology.

Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage

T. Iwama, T. Steiner, Chung Y. Hsu, 2020, Neurology.

Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial

Haruko Yamamoto, Y. Palesch, M. Koga, 2020, Cerebrovascular Diseases.

Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage

D. Hanley, T. Steiner, Haruko Yamamoto, 2019, Annals of neurology.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Michael D Hill, Joseph P Broderick, Yuko Y Palesch, 2013, The New England journal of medicine.

Collaterals at Angiography and Outcomes in the Interventional Management of Stroke (IMS) III Trial

Joseph P Broderick, Yuko Y Palesch, Pooja Khatri, 2014, Stroke.

r ecanalization and clinical Outcome of Occlusion s ites at Baseline cT angiography in the interventional Management of

A. Demchuk, J. Broderick, K. Cockroft, 2014 .

Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial

R. Conwit, V. Lioutas, M. Selim, 2022, Stroke.

Deferoxamine Mesylate in patients with intracerebral haemorrhage: a Multi-Center, Randomised, Double-Blind, Placebo-Controlled, Phase II Trial

C. Moy, M. Selim, G. Xi, 2019 .

Abstract 74: Early Arterial Recanalization After Intra-venous Tissue-Plasminogen-Activator Treatment in the Interventional Management of Stroke-3 Study

A. Demchuk, J. Broderick, T. Tomsick, 2014 .

Abstract 162: The Challenges of Decision-making Regarding Futility in a Randomized Trial: The IMS III Experience

J. Broderick, R. Woolson, Y. Palesch, 2013 .

An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism

C. Callaway, R. Silbergleit, J. Kline, 2022, Clinical trials.

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.

Hester F. Lingsma, A. Demchuk, C. Anderson, 2015, Stroke.

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

D. Beiser, K. Schulman, R. Silbergleit, 2021, The New England journal of medicine.

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

Michael D Hill, Joseph P Broderick, Yuko Y Palesch, 2014, The Lancet Neurology.

Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial

Vikesh K. Singh, A. Chak, V. Durkalski, 2016, Trials.

Correction to: Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial

Vikesh K. Singh, S. Varadarajulu, A. Chak, 2020, Trials.

Digestive Manifestations in Patients Hospitalized with COVID-19

M. Volk, L. Lara, G. Papachristou, 2020, medRxiv.

Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial

J. Mocco, C. Moy, M. Selim, 2021, Stroke.

Why Are Women Less Represented in Intracerebral Hemorrhage Trials?

G. Schlaug, C. Moy, J. Broderick, 2021, Stroke.

Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial

J. Suarez, A. Qureshi, I. Lobanova, 2020, Cerebrovascular Diseases.

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

R. Geocadin, J. Claassen, C. Falo, 2019, The Lancet Neurology.

Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial

J. Broderick, E. Jauch, A. Simpson, 2014, Stroke.

Challenges of Decision Making Regarding Futility in a Randomized Trial: The Interventional Management of Stroke III Experience

J. Broderick, R. Woolson, M. D. Di Tullio, 2014, Stroke.

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

A. Demchuk, C. Anderson, J. Broderick, 2015, Stroke.

Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019

Richard S. Kwon, Nicholas G. Brown, Vikesh K. Singh, 2020, Clinical Gastroenterology and Hepatology.

An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction.

Sean T. McCarthy, Vikesh K. Singh, S. Lo, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment: Interventional Management of Stroke (IMS)-III Trial

A. Demchuk, J. Broderick, T. Tomsick, 2014, Stroke.

Blood Pressure-Attained Analysis of ATACH 2 Trial

D. Hanley, R. Silbergleit, C. Moy, 2018, Stroke.

Characteristics of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Sphincter of Oddi Disorders

Vikesh K. Singh, S. Varadarajulu, A. Chak, 2022, Clinical Gastroenterology and Hepatology.

Observed Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

A. Demchuk, C. Anderson, J. Broderick, 2017, Journal of the American Heart Association.

Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial

Sean T. McCarthy, Vikesh K. Singh, S. Lo, 2018, Trials.

Should We Still Administer Prophylactic Rectal NSAIDs to Average-Risk Patients Undergoing ERCP?

B. Elmunzer, L. Foster, V. Durkalski, 2016, Gastroenterology.

Intravenous nicardipine for Japanese patients with acute intracerebral hemorrhage: an individual participant data analysis

S. Mayer, J. Jeng, D. Hanley, 2022, Hypertension Research.

Abstract 184: Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The IMS III Trial

J. Broderick, E. Jauch, A. Simpson, 2014 .

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

A. Demchuk, C. Anderson, J. Broderick, 2013, The New England journal of medicine.

Cigarette Smoking as a Risk Factor for Hematoma Expansion in Primary Intracerebral Hemorrhage: Analysis From a Randomized Clinical Trial

S. Majidi, C. Kellner, J. Suarez, 2023, Journal of the American Heart Association.

Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

S. Yusuf, R. Sacco, H. Diener, 2012, European heart journal.

Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial

A. Demchuk, J. Broderick, D. Liebeskind, 2015, American Journal of Neuroradiology.